Assisted reproductive technology (ART) are the medical procedures used for infertility treatment, in which eggs are surgically removed from the ovaries and are combined with the sperms in a laboratory. These eggs are then mixed with sperms to form embryos. ART procedure sometimes uses donor eggs, donor sperm, or previously frozen embryos. It may involve a surrogate or gestational carrier.

Request a sample copy of this report:- https://www.coherentmarketinsights.com/insight/request-sample/3041

Rising prevalence of infertility has led to an increase in demand for fertility treatments such as In Vitro Fertilization (IVF), Artificial Insemination-Intrauterine Insemination (AI-IUI) and others. In the U.S. prevalence of infertility is rising rapidly. For instance, according to the U.S. Department of Health & Human Services, in 2016, around 10 in 100 (6.1 million) women faced difficulty in getting pregnant.

In past few years there has been significant preference for assistive reproductive technology owing to rising prevalence and incidence of infertility in men and women..Such rising prevalence and incidence of infertility had led to an increase in number of assistive reproductive technology (ART) clinics in the U.S. According to the National Centers for Chronic Disease Prevention and Health Promotion, there are total 499 ART clinics in U.S, among which, 464 clinics had reported the ART related data, and in 2015 total 231,936 ART cycles are performed in U.S.

Market players are focused on expanding their portfolio of reproductive and fertility treatment products. For instance, Cooper Surgical Inc., a provider of fertility & genomic solutions, has an extensive portfolio ART management systems, IVF workstations, pipettes and needles for sperm or eggs transfer, catheters for embryos transfer, culture media and test kits. Moreover, Hamilton Thorne, In., also provides products such as sperm analyzers and a broad range of ART micropipettes.

FUJIFILM Irvine Scientific, Inc. provides water for assisted reproductive technology use, and also provides various products required for ART procedures. Moreover, Gonagen Medikal also offers various assistive reproductive technology such as IVF, ICSI and others, for infertility treatment.Companies are also adopting strategies to increase their share in the global assistive reproductive technology market and improve their product portfolio. For instance, in June 2018, Vitrolife AB and GE Healthcare partnered to improve their assisted reproductive technology offerings in the market.

Manufactures are taking several initiatives for creating awareness and providing training regarding ART technology. For instance, in June 2019 Cooper Surgical Inc. Conducted a workshop in India, to provide complete insight about the pre-requisites and techniques associated with ART, this workshop included lectures, demonstration, and hands-on work training of ART technologies. Moreover, in March 2019 Cooper Surgical Inc., conducted a workshop in Denmark on sperm selection techniques for ICSI procedures.

Global assistive reproductive technology market size was valued at US$ 23,669.2 Mn in 2018, and is expected to witness a CAGR of 5.3% during the forecast period (2019–2027).North America is expected to hold dominant position in global assistive reproductive technology market, due to increasing awareness about fertility treatments, and rising number of hospitals, and ART procedures. For instance, in U.S. Furthermore, Europe is expected to witness considerable growth in the global assistive reproductive technology market due to increasing number of ART cycles. For instance, in 2014 according to the European society of Human Reproduction and Embryology (ESHRE), around 800,000 treatment cycles were performed from 39 countries in Europe.

.Key players operating in the global assistive reproductive technology market include Cooper Surgical Inc., Hamilton Thorne, Inc., FUJIFILM Irvine Scientific, Inc., Merck KGaA, Nidacon International AB, Vitrolife AB, EMD Serono, Inc., INVO Bioscience, IVFtech ApS, Gonagen Medikal, Cook Medical LLC., and CellCura ASA.

Get the main link:- https://www.coherentmarketinsights.com/market-insight/assistive-reproductive-technology-market-3041

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Visit our news Website: http://www.coherentchronicle.com/